Выдержка

The potential contribution of trace amines (TA) to the pathophysiology of neuropsychiatric disorders makes it interesting to examine the effect of TA receptor ligands on schizophrenia biomarkers. We studied the effect of systemic administration of a putative Trace Amine-Associated Receptor 5 (TAAR5) agonist, alpha-NETA (2-(alpha-naphthoyl) ethyltrimethylammonium iodide), on the amplitude of the N40 event related potentials component and on the sensory gating (SG) index in C57BL/6 mice. It was found that low doses of alpha-NETA (2.5 mg/kg and 5 mg/kg) do not elicit a significant effect on the parameters of the N40 component and the SG index. However, the higher dose of alpha-NETA (10 mg/kg) induces a significant effect on the N40 component, but since a decrease in amplitude is observed on both the first and second stimuli in the pair, the SG index does not change. Thus, alpha-NETA administration causes a steady decrease in the N40 amplitude in response to both the first and second stimuli in the paired-click paradigm, and an increase in the N40 peak latency.

Язык оригиналаанглийский
Номер статьи134470
ЖурналNeuroscience Letters
Том712
DOI
СостояниеОпубликовано - 1 ноя 2019

Отпечаток

Sensory Gating
Evoked Potentials
Amines
Inbred C57BL Mouse
Schizophrenia
Biomarkers
Ligands
2-naphthoylethyltrimethylammonium

Предметные области Scopus

  • Нейробиология (все)

Цитировать

@article{f95ce5dd19f041e59432a8dbca0c128a,
title = "Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice",
abstract = "The potential contribution of trace amines (TA) to the pathophysiology of neuropsychiatric disorders makes it interesting to examine the effect of TA receptor ligands on schizophrenia biomarkers. We studied the effect of systemic administration of a putative Trace Amine-Associated Receptor 5 (TAAR5) agonist, alpha-NETA (2-(alpha-naphthoyl) ethyltrimethylammonium iodide), on the amplitude of the N40 event related potentials component and on the sensory gating (SG) index in C57BL/6 mice. It was found that low doses of alpha-NETA (2.5 mg/kg and 5 mg/kg) do not elicit a significant effect on the parameters of the N40 component and the SG index. However, the higher dose of alpha-NETA (10 mg/kg) induces a significant effect on the N40 component, but since a decrease in amplitude is observed on both the first and second stimuli in the pair, the SG index does not change. Thus, alpha-NETA administration causes a steady decrease in the N40 amplitude in response to both the first and second stimuli in the paired-click paradigm, and an increase in the N40 peak latency.",
keywords = "Alpha-NETA, Event related potentials, N40, Sensory gating, TAAR5",
author = "A.A. Aleksandrov and E.S. Dmitrieva and A.B. Volnova and V.M. Knyazeva and N.V. Polyakova and M.A. Ptukha and R.R. Gainetdinov",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.neulet.2019.134470",
language = "English",
volume = "712",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier",

}

Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice. / Aleksandrov, A.A.; Dmitrieva, E.S.; Volnova, A.B.; Knyazeva, V.M.; Polyakova, N.V.; Ptukha, M.A.; Gainetdinov, R.R.

В: Neuroscience Letters, Том 712, 134470, 01.11.2019.

Результат исследований: Научные публикации в периодических изданияхстатья

TY - JOUR

T1 - Effect of alpha-NETA on auditory event related potentials in sensory gating study paradigm in mice

AU - Aleksandrov, A.A.

AU - Dmitrieva, E.S.

AU - Volnova, A.B.

AU - Knyazeva, V.M.

AU - Polyakova, N.V.

AU - Ptukha, M.A.

AU - Gainetdinov, R.R.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - The potential contribution of trace amines (TA) to the pathophysiology of neuropsychiatric disorders makes it interesting to examine the effect of TA receptor ligands on schizophrenia biomarkers. We studied the effect of systemic administration of a putative Trace Amine-Associated Receptor 5 (TAAR5) agonist, alpha-NETA (2-(alpha-naphthoyl) ethyltrimethylammonium iodide), on the amplitude of the N40 event related potentials component and on the sensory gating (SG) index in C57BL/6 mice. It was found that low doses of alpha-NETA (2.5 mg/kg and 5 mg/kg) do not elicit a significant effect on the parameters of the N40 component and the SG index. However, the higher dose of alpha-NETA (10 mg/kg) induces a significant effect on the N40 component, but since a decrease in amplitude is observed on both the first and second stimuli in the pair, the SG index does not change. Thus, alpha-NETA administration causes a steady decrease in the N40 amplitude in response to both the first and second stimuli in the paired-click paradigm, and an increase in the N40 peak latency.

AB - The potential contribution of trace amines (TA) to the pathophysiology of neuropsychiatric disorders makes it interesting to examine the effect of TA receptor ligands on schizophrenia biomarkers. We studied the effect of systemic administration of a putative Trace Amine-Associated Receptor 5 (TAAR5) agonist, alpha-NETA (2-(alpha-naphthoyl) ethyltrimethylammonium iodide), on the amplitude of the N40 event related potentials component and on the sensory gating (SG) index in C57BL/6 mice. It was found that low doses of alpha-NETA (2.5 mg/kg and 5 mg/kg) do not elicit a significant effect on the parameters of the N40 component and the SG index. However, the higher dose of alpha-NETA (10 mg/kg) induces a significant effect on the N40 component, but since a decrease in amplitude is observed on both the first and second stimuli in the pair, the SG index does not change. Thus, alpha-NETA administration causes a steady decrease in the N40 amplitude in response to both the first and second stimuli in the paired-click paradigm, and an increase in the N40 peak latency.

KW - Alpha-NETA

KW - Event related potentials

KW - N40

KW - Sensory gating

KW - TAAR5

UR - http://www.scopus.com/inward/record.url?scp=85072074159&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2019.134470

DO - 10.1016/j.neulet.2019.134470

M3 - Article

VL - 712

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

M1 - 134470

ER -